Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-501-8 | CAS number: 13410-01-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian germ cell study: cytogenicity / chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: well-documented publication which meets basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- Chromosolmal effects of sodium selenite in vivo
- Author:
- Norppa H et al
- Year:
- 1 980
- Bibliographic source:
- Hereditas 93: 97-99 (1980)
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- A single intraperitoneal injection with 0.8 mg Selenium/kg bw (= approx 20% of of the LD50 of selenium for mice) was administered and effects wre assessed after 24h. More details of the followed method are provided in the original publication..
- GLP compliance:
- not specified
- Type of assay:
- chromosome aberration assay
Test material
- Reference substance name:
- Sodium selenite
- EC Number:
- 233-267-9
- EC Name:
- Sodium selenite
- Cas Number:
- 10102-18-8
- Molecular formula:
- H2O3Se.2Na
- IUPAC Name:
- disodium selenite
- Details on test material:
- - Name of test material (as cited in study report): sodium selenite
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Medica
- Age at study initiation: 3 month
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- sterile water
- Details on exposure:
- Single intraperitoneal injection, 0.8 mg Selenium/kg bw. This dose is about one fifth of the LD50 of selenium for mice.
- Duration of treatment / exposure:
- 24 hours
- Frequency of treatment:
- single intraperitoneal injection
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0.8 mg Selenium/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- test substance: 12 males
control: 6 males - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- no
Examinations
- Tissues and cell types examined:
- Bone marrow cells
Spermatocytes - Details of tissue and slide preparation:
- 21 hours after exposure Colcemide (10µg/g bw) was injected i.p. into all animals. Three hours later the mice were killed by ether narcosis, and cytogenitec preparations were made of bone marrow and testis.
Bone marrow was rinsed out from both femurs by a medium consisting of three parts of Minimal Essential Medium (Orion), one part of pooled human Rh-positive AB serum and 0.05 µg/mL of Colcemid. Slides were prepared by the air drying method after 20 min. hypotonic treatment in pre-warmed (37°C), 0.075 mKCl and fixation in methanol-glacial acetic acid (3:1). They were stained in 5% Giemsa for 10 min. If possible, 100 diploid bone marrow metaphases were analyzed per animal from coded slides by one microscopist for the presence of chromosome and chromatid type aberrations and gaps.
Spermatocytes were prepared and stained according to the method described by Hoo and Bowles (1971). For each mouse, the frequency of cells with gonosomal and autosomal univalent, multivalents and fragments was determined, if possible, from 100 diakinesis-metaphase primary spermatocytes.
An interval of only 24 hours between the treatment and the evaluation of chromosomal changes in primary spermatocytes means that actually diakinesis has been treated. This stage is generally rather insensitive to to clastogens. But as some chemicals have been reported to affect even at this phase, the primary spermatocyte analysis is also included in the study. - Statistics:
- Results were evaluated statistically by Fishers exact probability test (2-tailed).
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Negative controls validity:
- valid
- Additional information on results:
- Both in the controls and selenite-treated mice, the frequencies of cells with chromosomal aberrations and gaps were low. Observed aberrations were chromatid type minutes or breaks. There was no difference in the occurrence of these lesions between the two groups.
No significant difference existed between the Sodium selenite treated and control mice for the frequencies of primary spermatocytes with univalents or fragments. No multivalents were found from either of the groups.
The dose of sodium selenite injected into the mice is high enough to induce toxic effect. Still, no rise was found in chromosomal aberration rates in bone marrow cells or primary spermatocytes of these animals.
Any other information on results incl. tables
Result from chromosomal abnormalities in bone marrow cells:
Treatment i.p. |
No. of animals |
No of cells evaluated: |
Aberrations (gaps excluded) |
Gaps only |
Control
|
6 |
264 |
3 (1.1 %) |
2 (0.8 %) |
Sodium selenite (0.8 mg/kg bw) |
12 |
666 |
3 (0.5 %) |
9 (1.4 %) |
Result from chromosomal abnormalities in primary spermatocytes:
Treatment i.p. |
No. of animals |
No of cells evaluated: |
With fragments |
With univalent |
|
Autosomal |
Gonosomal |
||||
Control |
6 |
225 |
1 (0.4 %) |
0 |
2 (0.9 %) |
Sodium selenite (0.8 mg/kg bw |
12 |
982 |
2 (0.2 %) |
1 (0.1 %) |
1 (0.9 %) |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Both in the controls and selenite-treated male mice, there was no difference between structural chromosomal aberrations or gaps in bone marrow cells and in the number of metaphase-diakinesis stages of primary spermatocytes with chromosomal fragments, autosomal univalents, or XY-univalents. - Executive summary:
Sodium selenite was injected intraperitoneally (0.8 mg Se/kg bw) into 12 male NMRI mice, while 6 control animals received sterile water. After 24 h, cytogenetic preparations of bone marrow and testis were made. Bone marrow of the Sodium selenite treated mice contained no more cells with structural chromosomal aberrations (0.5 % in 666 cells) or gaps (1.4 %) than that of the controls (1.1 % aberrations, 0.8 % gaps, in 264 cells). There was also no difference between the two groups in the number of metaphase-diakinesis stages of primary spermatocytes with chromosomal fragments (0.2 % in 982 cells in sodium selenite – group, 0.4 % in 225 cells in controls), autosomal univalent (0.1 % in sodium selenite – group, 0.0 % in controls), or XY-univalents (0.1 % in sodium selenite – group, 0.9 % in controls).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)